Assessment of the efficacy of antimalarial drugs in Tarapacá, in the Colombian Amazon basin;Evaluación de la eficacia de los medicamentos antimaláricos en Tarapacá, Amazonas Colombiano

Biomedica

Volumn 27, Issue 1, 2007, Pages 133-140

  Osorio, Lyda ^a,c   del Pilar Pérez, Ligia ^b   González, Iveth J ^a  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^b Laboratorio Departamental de Salud Publica de Amazonas   (Colombia)

^c NONE   (Colombia)

Author keywords

Amazonian ecosystem; Colombia; Drug therapy; Falciparum prevention control; Malaria; Malaria vivax prevention control

Indexed keywords

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

AMODIAQUINE; ANTIMALARIAL AGENT; PYRIMETHAMINE; SULFADOXINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COLOMBIA; FEMALE; HUMAN; INFANT; MALARIA; MALARIA FALCIPARUM; MALE; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AMODIAQUINE; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; COLOMBIA; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MIDDLE AGED; PYRIMETHAMINE; SULFADOXINE;

EID: 35448941873     PISSN: 01204157     EISSN: None     Source Type: Journal    
DOI: 10.7705/biomedica.v27i1.239     Document Type: Article

References (22)

1. Zambrano P. Informe final de malaria, semanas 1 a 52 Colombia, 2005. Inf Quinc Epidemiol Nac 2006;11:49-53.
2. Moore DV, Lanier JE. Observations of two Plasmodium falciparum infections with an abnormal response to chloroquine. Am J Trop Med Hyg 1961;10:5-9.
3. López Y, Arroyave A, Salazar A. Evaluación de la resistencia in vivo a los medicamentos antimaláricos El Bagre, Antioquia, 1998. Rev Epidemiol Antioquia 1999;24:181-94.
4. Blair S, Lacharme L, Carmona J, Tobón A. Resistencia de Plasmodium falciparum a tres fármacos antimaláricos an Turbo (Antioquia, Colombia) 1998. Rev Panam Salud Pública 2001; 9:23-9.
5. Blair S, Lacharme-Lora L, Carmona-Fonseca J. Resistance of Plasmodium falciparum to antimalarial drugs in Zaragoza (Antioquia, Colombia), 1998. Mem Inst Oswaldo Cruz 2002;97:401-6.
6. Castillo CM, Osorio LE, Palma GI. Assessment of the therapeutic response of Plasmodium vivax and Plasmodium falciparum to chloroquine in a malaria transmission free area in Colombia. Mem Inst Oswaldo Cruz 2002;97:559-62.
7. Osorio LE, Giraldo LE, Grajales LF,. Arriaga AL, Andrade AL, Ruebush TK 2nd et al. Assessment of therapeutic response of Plasmodium falciparum to chloroquine and sulfadoxine/ pyrimethamine in a low malaria transmission area in Colombia. Am J Trop Med Hyg 1999;61:968-72.
8. Ministerio de Salud de Colombia. Guía de atención clíníca para el diagnóstico y tratamiento de la malaria. Bogotá: Ministerio de Salud; 1999.
9. Alecrim M das G, Alecrim WD, do Albuquerque BC, Dourado HV, Wanssa M do C. Resistance of Plasmodium falciparum in the Brazilian Amazonas to the combination of sulfadoxine and pyrimethamine. Rev Inst Med Trop Sao Paulo 1982;24 (6 suppl):44-7.
10. Magill AJ, Zegarra J, Garcia C, Marquino W, Ruebush TK 2nd. Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru. Rev Soc Bras Med Trop 2004;37:279-81.
11. Alecrim M das G, Alecrim W, Macedo V. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. Rev Soc Bras Med Trop 1999;32:67-8.
12. Baird JK, Wlady I, Fryauff DJ, Sutanihardja MA, Leksana B, Widjaya H et al. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am J Trop Med Hyg 1997;56:627-31.
13. Soto J, Toledo J, Gutiérrez P, Luzz M, Llinas N, Codeño N et al. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg 2001;65:90-3.
14. World Health Organization. Assessment and monitoring of antimalarial drug efficacy for the treatment of of uncomplicated P. falciparum malaria. Report No.: WHO/HTM/RBM/2003.50. Geneva: WHO; 2003.
15. World Health Organization/Pan American Health Organization. Assessment of therapeutic efficacy of medicaments to treat uncomplicated P. falciparum malaria in the Americas. Report No.: PS/HCP/HCT/113/ 98. Washington: WHO, OPS; 1998.
16. Espinal CA, Cortes GT, Guerra P, Arias AE. Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia. Am J Trop Med Hyg 1985;34:675-80.
17. Magris M, Riggione F. Susceptibilidad de Plasmodium falciparum in vitro a la cloroquina, amodiaquina, quinina y pirimetamina-sulfadoxina en el estado Amazonas, Venezuela. Acta Científica Venezolana 1994;45 (Supl 1):250.
18. Blair S, Carmona-Fonseca J, Piñeros JG, Rios A, Álvarez T, Álvarez G et al. Therapeutic efficacy test in malaria falciparum in Antioquia, Colombia. Malar J 2006;5:14.
19. Méndez F, Muñoz A, Carrasquilla G, Jurado D, Arevalo-Herrera M, Cortese J et al. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Am J Epidemiol 2002;156:230-8.
20. Noedl H, Wongsrichanalal C, Wernsdorfer WH. Malaria drug-sensitivity testing: new assays, new perspectives. Trends Parasitol 2003;19:175-81.
21. Kublin J, Richard W, Shankar A, Quintana J, Gilman R, Aramburu J et al. Molecular assays for surveillance of antifolate-resistance malaria. Lancet 1998;351:1629.
22. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley P et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 1997;176:1590-6.